Purpose: To examine the experience of therapeutic touch in the lives of postpartum women.
Methods: Qualitative study of five postpartum women who participated in therapeutic touch for 2 months during home visits that focused on postpartum issues and concerns. The visits were audiotaped and transcribed. Data were coded and classified; linkages between categories were sought.
Results: Five themes or essences of the experience emerged: Feeling Relaxed, Feeling Open, Feeling Cared For, Feeling Connected, and Feeling Skeptical.
Clinical Implications: The women and the researcher experienced many positive emotions during the home visits. Although it is unknown whether it was the visit, the interaction, or the therapeutic touch that helped the women feel cared for, the experience of participating in therapeutic touch seemed to add a dimension of mutual caring that added a special and unique quality to the home visit.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/00005721-200201000-00014 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Neuroprotective effect of nano-carboxymethyl chitosan from Doryteuthis sibogae against rotenone-induced Parkinson's Disease in the Zebrafish model.
Behav Brain Res
March 2025
Native Medicine and Marine Pharmacology Laboratory, Faculty of Allied Health Sciences. Electronic address:
This study investigates the neuroprotective effects of N-carboxymethyl chitosan (N-CMC) against rotenone (ROT)-induced Parkinson's disease (PD) in a zebrafish (ZF) model. In vivo experiments revealed that ROT-exposed ZF larvae exhibited reduced locomotor activity, increased edge preference, and impaired touch response, while N-CMC treatment significantly improved these behavioral parameters. The reactive oxygen species (ROS) levels in ROT-exposed larvae were elevated (37.
View Article and Find Full Text PDFSpinal dorsal horn neurons involved in the alleviating effects of cannabinoid receptor agonists on neuropathic allodynia-like behaviors in rats.
J Pharmacol Sci
April 2025
Department of Molecular and System Pharmacology, Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan; Kyushu University Institute for Advanced Study, Fukuoka, Japan. Electronic address:
Mechanical allodynia, the pain caused by innocuous tactile stimuli, is a hallmark symptom of neuropathic pain that is often resistant to currently available treatments. Cannabinoids are widely used for pain management; however, their therapeutic mechanisms for neuropathic mechanical allodynia remain unclear. Using transgenic rats that enable to optogenetically stimulate touch-sensing Aβ fibers in the skin, we found that the intrathecal administration of the synthetic cannabinoid, WIN 55,212-2, alleviated the Aβ fiber-derived neuropathic allodynia.
View Article and Find Full Text PDFInflammation in atherosclerotic cardiovascular disease: From diagnosis to treatment.
Eur J Clin Invest
March 2025
Technical University of Munich, School of Medicine and Health, German Heart Centre, TUM University Hospital, Munich, Germany.
Background: Targeting inflammation offers a unique possibility to address residual cardiovascular risk in almost two thirds of all patients with prevalent atherosclerotic cardiovascular disease (ASCVD). However, despite FDA approval and the ESC 2024 Guidelines for the Management of Chronic Coronary Syndrome recommendations to implement low-dose colchicine (0.5 mg daily) in the secondary prevention of ASCVD patients with residual inflammatory risk, its clinical adoption is still limited.
View Article and Find Full Text PDFGetting in Touch with Touch: The Importance of Studying Touch in MDMA-Assisted Therapy and the Development of a New Self-Report Measure.
Psychedelic Med (New Rochelle)
March 2024
Department of Mental Health, Veterans Affairs Portland Health Care System, Portland, Oregon, USA.
Background: MDMA-assisted therapy (MDMA-AT) is an emerging treatment modality, with recent phase 3 trials indicating its potential for regulatory approval. Central to this therapy is the role of touch, yet its empirical evaluation in MDMA-AT, and psychotherapy in general, remains limited. The use of touch in combination with MDMA raises concerns about power imbalances and ethical boundaries.
View Article and Find Full Text PDFEvolving Guidelines for the Use of Touch During a Clinical Trial of Group Psilocybin-Assisted Therapy.
Psychedelic Med (New Rochelle)
December 2024
Orion Center for Integrative Medicine, Seattle, Washington, USA.
For a new clinical trial testing a group retreat-based format of psilocybin-assisted therapy, our research team created an initial set of practice guidelines that aimed to describe facilitator use of touch in a way that is ethical, supportive, and minimizes harm. In our first three retreats, however, we had two unexpected experiences with touch that led us to iterate our initial guidelines into a new version of guidelines. In this Technical Report, we describe our evolving guidelines specifying acceptable practices for facilitator use of touch to ensure a safe, supportive, and therapeutic participant experience.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!